Nanoform Finland Oyj (STO:NANOFS)

Market Cap	1.06B
Revenue (ttm)	44.14M
Net Income (ttm)	-251.74M
Shares Out	n/a
EPS (ttm)	-2.92
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,412
Average Volume	33,853
Open	12.10
Previous Close	12.12
Day's Range	12.08 - 12.60
52-Week Range	8.00 - 21.00
Beta	0.61
RSI	52.54
Earnings Date	Nov 12, 2025

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 181
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: NANOFS

Financial Performance

In 2024, Nanoform Finland Oyj's revenue was 3.66 million, an increase of 42.70% compared to the previous year's 2.57 million. Losses were -23.43 million, 12.9% more than in 2023.

Financial numbers in EUR